No insider purchase over the last 90 days. The latest, by 루하갈락티코스, was filed 14 Jul 2026.
LabGenomics Co., Ltd.: what insiders have been doing
Every trade that managers of LabGenomics Co., Ltd. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Between 31 October 2025 and 31 October 2026, 7 insiders published 12 filings.
Purchases and sales both appear in the filings: 4 purchases (3 insiders) and 7 sales (5 insiders). The totals do not cover 11 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 major shareholder.
The latest purchase dates back some time: it was published 118 days ago, on 14 July 2026. Filings reach the DART (FSS) feed a median of 8 days after the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
With 12 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for LabGenomics Co., Ltd. go back to 2021, with 54 purchases and 12 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySale+1 other insider
Since the insiders bought
- -28.3%Entry ₩699 · Close at T+90 ₩501
- -28.3%Entry ₩699 · Close at T+90 ₩501
- -32.2%Entry ₩890 · Close at T+90 ₩604
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2025FY ended December 2025 · cache
- 24,096 sharesShareKRXDART:20260930000568
- 22,888 sharesShareKRXDART:20260930000562
- 69,874 sharesShareKRXDART:20260930000556
- 17,969,773 sharesShareKRXDART:20260930000549
- Other0DART
- Other0DART
- Other0DART
- 1,240,100 sharesKRXDART:20260714000481Canonical exit: 12 Oct 2026 (T+90)
- 1,240,100 sharesShareKRXDART:20260714000487Canonical exit: 12 Oct 2026 (T+90)
- 5,434,801 sharesShareKRXDART:20260616000347
- 1,893,891 sharesKRXDART:20260612000666Canonical exit: 10 Sept 2026 (T+90)
- 13,642,564 sharesKRXDART:20260528000522Canonical exit: 18 Aug 2026 (T+90)
- 28,968 sharesShareKRXDART:20260527000314
- 7,749,660 sharesKRXDART:20260526000259
- ●Executives0DART
- 322,386 sharesKRXDART:20250709000132
- ●Executives0DART
- 213,627 sharesKRXDART:20250409001780Canonical exit: 10 Apr 2025 (T+90)
- 523,267 sharesKRXDART:20250109000112
- 1,225,806 sharesKRXDART:20241008000132Canonical exit: 5 Nov 2024 (T+90)
- 246,206 sharesKRXDART:20240820000360
- 785,822 sharesKRXDART:20240710000329
- ShareKRXDART:20240701000605Canonical exit: 17 Apr 2024 (T+90)
- 4,305,417 sharesKRXDART:20240701000611Canonical exit: 22 Sept 2024 (T+90)
- 42,000 sharesKRXDART:20240618000241Canonical exit: 16 Sept 2024 (T+90)
25 of 79 declarations
About LabGenomics Co., Ltd.
랩지노믹스 is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative diagnostic and treatment solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
